title: Flotetuzumab
text: # Flotetuzumab
  
  Flotetuzumab (INN; development code MGD006) is a bispecific antibody designed for the treatment of acute myeloid leukemia.
  
  This drug is being developed by MacroGenics, Inc.
  
  